| Literature DB >> 24744692 |
Gauri Devi Bajju1, Sujata Kundan1, Madhulika Bhagat2, Deepmala Gupta1, Ashu Kapahi1, Geeta Devi1.
Abstract
Results of investigation of the physicochemical properties of zinc complexes containing substituted class="Chemical">phenols as axial ligand having general formula [Entities:
Year: 2014 PMID: 24744692 PMCID: PMC3976806 DOI: 10.1155/2014/782762
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1General synthetic route for the synthesis of zinc(II)-5,10,15,20-meso-tetra(para-methylphenyl)porphyrin containing different phenols as axial ligand.
1H NMR dataa of free base H2-t(p-CH3)PP and axially ligated X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) in CDCl3 at 298 K.
| Porphyrins |
| Imino protons |
| Other protons |
|---|---|---|---|---|
| H2t( | 8.86 (s) | −2.77 (s) | 8.11(d, 8H, H | 2.64(s, 12H, Hme) |
| Zn-t( | 8.65 (s) | — | 8.06(d, 8H, H | 2.69(s, 12H, Hme) |
| phO-Zn-t( | 8.99 (s) | — | 8.41(d, 10H, H | 2.71(s, 12H, Hme) |
|
| 9.2 (s) | — | 8.29(d, 10H, H | 2.9(s, 12H, Hme) |
|
| 8.93 (s) | — | 8.22(d, 10H, H | 2.31(s, 12H, Hme) |
|
| 8.90 (s) | — | 8.26(d, 10H, H | 2.36(s, 12H, Hme) |
| 2,4-Cl2phO-Zn-t( | 9.4 (s) | — | 8.33(d, 10H, H | 3.3(s, 12H, Hme) |
|
| 9.01 (s) | — | 8.39(d, 10H, H | 2.65(s, 12H, Hme) |
a δ in ppm; the nature of splitting pattern(s): (s = singlet, d = doublet, t = triplet, and m = multiplet); number of proton(s) and their location in the porphyrins, respectively, are given in parenthesis; o = ortho; p = para; m = meta.
Fluorescence spectral data of axially ligated compound of X-Zn-t(p-CH3)PP (X = different phenols as axial ligands) in methanol solvent using excitation at ~550 nm.
| Porphyrins |
|
|---|---|
| Zn-t( | 590, 640 |
|
| 612, 660 |
In vitro efficacy of axially ligated X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) against the pathogen Sclerotium rolfsi. Colony diameter of control C = 90 mm.
| Porphyrins | Different concentration | Colony diameter | % inhibition |
|---|---|---|---|
|
| 100 | 52.62 | 41.53 |
|
| |||
|
| 100 | 49.12 | 45.4 |
|
| |||
|
| 100 | 51 | 43.33 |
|
| |||
|
| 100 | 48 | 46.66 |
|
| |||
|
| 100 | 37.5 | 58.33 |
Figure 11H NMR spectra of p-NO2phO-Zn-t-(p-CH3)PP in CDCl3 at 298 K. Starred peaks are solvents impurities.
Figure 21H NMR spectra of p-OCH3phO-Zn-t-(p-CH3)PP in CDCl3 at 298 K. Starred peaks are solvents impurities.
Optical absorption data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) in CHCl3 showing λ max together with log ε and ν 1/2.
| Porphyrins | B-bands | Q-bands |
|---|---|---|
| H2t( | 430, (5.986), 989.4 | 516, 553, 592, 649 |
| Zn-t( | 432, (5.824), (995.3) | 564.2, (4.218), 789.3; |
| phO-Zn-t( | 430.2, (5.771), (997.9) | 563.8, (4.312), 785.1; |
|
| 431.4, (5.798), (1008) | 564.0, (4.418), 829.4; |
|
| 432, (5.833), (980.8) | 569.4, (4.484), 826.2; |
|
| 431.9, (5.845), (978.9) | 570.2, (4.521), 789.3; |
|
| 432.4, (5.808), (984.1) | 567, (4.448), 822.4; |
|
| 433.4, (5.806), (998) | 572.4, (4.527), 796.2; |
|
| 433.2, (5.696), (992.4) | 570.4, (4.456), 698.6; |
|
| 433.9, (5.859), (986.6) | 570.9, (4.432), 699.4; |
|
| 431, (5.964), (987.1) | 565, (4.643), 762.1; |
|
| 431.8, (5.839), (986.4) | 564, (4.682), 760.9; |
|
| 431.6, (5.969), (986.9) | 564, (4.861), 760.6; |
|
| 428, (5.942), (998.9) | 546, (4.549), 854.2; |
|
| 427, (5.841), (995.2) | 546, (4.643), 846.9; |
|
| 427, (5.872), (995.6) | 546, (4.516), 842.8; |
|
| 426, (5.646), (1014.4) | 547, (4.569), 872.3; |
|
| 425, (5.781), (992.5) | 548, (4.439), 781.9; |
|
| 425, (5.841), (998.6) | 548, (4.598), 785.2; |
Optical absorption data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) recorded in different solvents with calculated “f” values.
| Porphyrins | Solvent | B-band |
Q-bands |
Oscillator strength | ||
|---|---|---|---|---|---|---|
| Q (1, 0) | Q (0, 0) | B-band | Q-band | |||
|
| MtOH | 435.9, 714 | 589, 925 | 604, 531 | 0.140635 | 0.206755 |
| CHCl3 | 433.9, 437 | 570.9, 1096 | 604.6, 532 | 0.044387 | 0.253434 | |
| CH2Cl2 | 432.8, 542 | 568.4, 679 | 601, 740 | 0.0436727 | 0.1878264 | |
| CCl4 | 430, 631 | 560.1, 594 | 586, 447 | 0.115715 | 0.1331380 | |
|
| ||||||
|
| MtOH | 433.4, 615 | 564, 459 | 592, 525 | 0.19106399 | 0.0951163 |
| CHCl3 | 425, 750 | 548, 455 | 579, 549 | 0.1807739 | 0.0643726 | |
| CH2Cl2 | 424, 857 | 546, 426 | 573, 503 | 0.14803905 | 0.0757845 | |
| CCl4 | 422.8, 820 | 542, 561 | 568, 511 | 0.1416476 | 0.1341536 | |
|
| ||||||
|
| MtOH | 429, 686 | 584, 485 | 616.2, 555 | 0.0881638 | 0.1030306 |
| CHCl3 | 427, 770 | 546, 426 | 580, 463 | 0.2218310 | 0.0904969 | |
| CH2Cl2 | 427.8, 607 | 544.8, 470 | 577.4, 367 | 0.0838246 | 0.0852483 | |
| CCl4 | 424.4, 766 | 542.9, 540 | 540.2, 584 | 0.1439980 | 0.0572695 | |
Figure 3UV-Visible spectra of p-NH2phO-Zn-t(p-CH3)PP in different solvents.
Main vibrational frequencies corresponding to the various groups in X-Zn-t(p-CH3)PP (X = different phenols as axial ligand).
|
|
Mass data (m/z ratio) and elemental analytical data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) along with their calculated values.
| Porphyrins | Molecular formula |
| Percentage | ||
|---|---|---|---|---|---|
| C | H | N | |||
| phO-Zn-t( | C54H41N4ZnO | 828.39 | 78.29 | 4.99 | 6.76 |
|
| C58H43N4ZnO | 878.90 | 79.31 | 4.94 | 6.38 |
|
| C54H43N5ZnO | 843.39 | 76.81 | 5.13 | 8.3 |
|
| C55H43N4ZnO2 | 858.53 | 76.94 | 5.05 | 6.53 |
|
| C54H40N4ZnOCl | 862.95 | 75.16 | 4.67 | 6.49 |
| 2,4Cl2phO-Zn-t( | C54H39N4ZnOCl2 | 897.39 | 72.27 | 4.38 | 6.24 |
Figure 4Fluorescence spectral data of Zn-t(p-CH3)PP and p-NH2phO-Zn-t(p-CH3)PP in methanol at excitation 550 nm.
Figure 5TG curve (a) and DTA curve (b) of p-OCH3phO-Zn-t(p-CH3)PP.
Figure 6(a) Antifungal activity of p-NH2phO-Zn-t(p-CH3)PP, (b) antifungal activity of p-OCH3phO-Zn-t(p-CH3)PP, (c) antifungal activity of p-NO2phO-Zn-t(p-CH3)PP, and (d) antifungal activity of p-ClphO-Zn-t(p-CH3)PP.
Figure 7In vitro cytotoxicity of p-NO2phO-Zn-t(p-CH3)PP complexes against human cancer cell lines.
Figure 8Proposed structure of axially ligated zinc(II) porphyrins.